StageZero Life Sciences Ltd (SZLS) — Cash Flow Reinvestment Rate
Latest as of September 2023:
0.00x
StageZero Life Sciences Ltd (SZLS) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$47.82K. Check StageZero Life Sciences Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
CA$0.00
Capex + Investments
Operating Cash Flow
CA$47.82K
CAD
Capital Expenditures
CA$0.00
CAD
Annual Cash Flow Reinvestment Rate for StageZero Life Sciences Ltd (None–None)
Year-by-year capital reinvestment analysis for StageZero Life Sciences Ltd. For live market cap and broader valuation context, see market cap of StageZero Life Sciences Ltd.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow